Alterity Therapeutics Limited
ATH
Rangering i aksjer
#25796
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Aksjekurs
$0.20100617
Markedsverdi
$43.92M
Endring (1 dag)
0.00%
Endring (1 år)
-42.57%
Land
AU
Handel Alterity Therapeutics Limited (ATH)
Kategori
Healthcare
Markedsverdi av Alterity Therapeutics Limited(ATH)
Markedsverdi: $43.92M
Per October 2026 har Alterity Therapeutics Limited en markedsverdi på $43.92M. Dette gjør Alterity Therapeutics Limited til det 25796th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Alterity Therapeutics Limited fra 2012 til 2026
ATH sammenlignet med topp 5 mest populære stocks
